Literature DB >> 16757568

Serious delayed hypersensitivity reaction to oxaliplatin.

R S de Vries, E J Mattijssen, A A van Sorge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16757568     DOI： 10.1093/annonc/mdl116

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.

Authors:  Maeve Lowery; Manish A Shah; Elizabeth Smyth; Andrew Epstein; Amiel Segal; Ora Rosengarten; Rut Isacson; Lior Drukker; Anner Keinan; Meir Rachkiman; Petachae Reissman; Alberto Gabizon; David Kelsen; Eileen M O'Reilly
Journal:  J Gastrointest Cancer       Date:  2011-09

2.  Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Authors:  Nektaria Makrilia; Ekaterini Syrigou; Ioannis Kaklamanos; Leonidas Manolopoulos; Muhammad Wasif Saif
Journal:  Met Based Drugs       Date:  2010-09-20

3.  Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction.

Authors:  Simona Potenza; Guglielmo Nasti; Alessandro Ottaiano; Ottaiano Alessandro; Amelia Filippelli; Francesco Rossi; Annalisa Capuano
Journal:  Invest New Drugs       Date:  2009-04-08       Impact factor: 3.850

Review 4.  Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.

Authors:  Ekaterini Syrigou; Kostas Syrigos; M Wasif Saif
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

5.  Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment.

Authors:  Takaaki Kobayashi; Tadahiko Masaki; Koji Kogawa; Hiroyoshi Matsuoka; Masanori Sugiyama
Journal:  Int Surg       Date:  2013 Oct-Dec

6.  Effectiveness of oxaliplatin desensitization protocols.

Authors:  Susana Cortijo-Cascajares; Inmaculada Nacle-López; Ignacio García-Escobar; María José Aguilella-Vizcaíno; Alberto Herreros-de-Tejada; Hernán Cortés-Funes Castro; Miguel-Ángel Calleja-Hernández
Journal:  Clin Transl Oncol       Date:  2012-07-25       Impact factor: 3.405
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.